{"id":2780,"date":"2013-10-09T12:14:33","date_gmt":"2013-10-09T12:14:33","guid":{"rendered":"\/?p=2780"},"modified":"2013-10-09T12:19:17","modified_gmt":"2013-10-09T12:19:17","slug":"titan-pharmaceuticals-inc-otcbbttnp-pushed-down-by-panicky-sellers","status":"publish","type":"post","link":"\/articles\/titan-pharmaceuticals-inc-otcbbttnp-pushed-down-by-panicky-sellers\/","title":{"rendered":"Titan Pharmaceuticals, Inc. (OTCBB:TTNP) Pushed Down by Panicky Sellers"},"content":{"rendered":"

Titan Pharmaceuticals, Inc. (OTCBB:TTNP<\/a>) broke a five-day buying streak, as the company struggles to either make a big climb or retreat to its lower levels. On Tuesday, TTNP<\/a> lost more than 7% to stand at $1.07, on dollar volumes of above $5 million. \"4TTNP0910.png\" <\/p>\n

The company was supposed to give a written update for filing a set of documents required to set up an FDA meeting in November. But no such PR piece appeared, and that may have caused concern.<\/p>\n

TTNP<\/a> is also not promoted, and while there is talk of prices reaching as high as $10, the ticker could not keep or improve the $1.16 levels. Investors’ opinions are disparate, some pointing toward the possibility that TTNP<\/a> is still nothing more than a quick day trade. And TTNP<\/a> is indeed volatile, with a somehow wide daily range.\"ELTP0910.png\"<\/p>\n

But in case the fully-researched anti-addiction therapy gets approved, TTNP<\/a> would receive a major boost from patent revenues, which so far came in only with an $18 million preliminary payment, awaiting a further $50 million upon approval, and awaiting further royalties. Probably the TTNP<\/a> shares should move to reflect that value. Now, TTNP<\/a> still has a long time to make the week memorable by bridging the gap from May.<\/p>\n

TTNP<\/a> is rising among a group of several pharmaceutical tickers that exhibit great value and move without the boost from a promotion. Elite Pharmaceuticals, Inc. (OTCBB:ELTP<\/a>), a well-developed pharmaceutical company, aims to repeat its peaks, as it grew again to 14 cents on dollar volumes above $818,000.<\/p>\n

And while at a lower price range, Advanced Cell Technology, Inc. (OTCBB:ACTC<\/a>) has been making a recovery, in the last few days standing more stably in the 7-cents range. ACTC<\/a> is making bolder claims based on stem cells, and so far has yet to offer finished and accepted therapies. Still, the company of Dr. Robert Lanza fame is a staple among the most actively traded penny stocks.<\/p>\n

In the case of TTNP<\/a>, panicky sellers could do much worse, especially with a lack of good news. Still, the FDA meeting in mid-November will be the event that can ensure more days of good investor interest. It is best to decide on your preferred time frame for TTNP<\/a> and avoid investing if you could be hurt by the volatility that often accompanies this ticker.<\/p>\n","protected":false},"excerpt":{"rendered":"

Titan Pharmaceuticals, Inc. (OTCBB:TTNP) broke a five-day buying streak, as the company struggles to either make a big climb or retreat to its lower levels. On Tuesday, TTNP lost more than 7% to stand...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[199,797,11],"class_list":["post-2780","post","type-post","status-publish","format-standard","hentry","category-news","tag-actc","tag-eltp","tag-ttnp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=2780"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2780\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=2780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=2780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=2780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}